U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252453) titled 'Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia' on Nov. 17.
Brief Summary: In this Study investigator is comparing the effectiveness and outcomes of two drugs used un the treatment of trigeminal neuralgia , Carbamazepine vs Oxcarbazepine
Study Start Date: May 20
Study Type: INTERVENTIONAL
Condition:
Trigeminal Neuralgia
Intervention:
DRUG: Carbamazepine
Carbamazepine is a conventional drug used to treat trigeminal neuralgia. It primarily works by blocking voltage-gated sodium channels in nerve cells, which prevents rapid and repetitive firing of action potentials and reduces abnormal electr...